07 Jan 2001

Cefakliman® (Cefakliman® Tabletten) - Deutschland

Updated: 07 Jan 2001


Klimakterische Ausfallserscheinungen.

Cefakliman® Description, Presentation and Dosage

Cefakliman® Description

Cefakliman® Drug Class Description


Cefakliman® Drug Description

1 Tbl. enth.: Lachesis D12 10 mg, Cimicifuga D5 10 mg, Sepia D5 10 mg, Lilium tigrinum D5 10 mg.

Cefakliman® Generic Name

Cefakliman® Tabletten

Cefakliman® Presentation

Cefakliman® Presentation


Cefakliman® Manufacturer


Related Learning Zones

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this free resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately. Content is arranged into sections with disease awareness information, mode of action videos, first-line treatment options, links to useful external hyperammonaemia content and more… 

Type 1 Childhood Diabetes CME

Type 1 Childhood Diabetes CME

In this EACCME-accredited online CME activity Individual Patient Management in Type 1 Childhood Diabetes, healthcare professionals will learn how to assess the psychosocial wellbeing of young patients with type 1 diabetes. 

Upon successful completion of this activity, healthcare professionals (such as endocrinologists, paediatricians, paediatric endocrinologists, diabetes specialists, specialist nurses, primary care physicians) will be awarded 1 European CME credit (ECMEC).

Cefakliman® Dosage

Cefakliman® Adult Dosage

Lactose, Magnesiumstearat.

Cefakliman® Precautions, Reactions and Contraindications

Cefakliman® Special Precautions

Related Drugs - Women's Health and Obs/Gyn

Back to top